The forecasted sales for antiinfective medicines in Japan indicate a consistent decline from 2024 to 2028, starting at 906.5 million USD in 2024 and dropping to 779.4 million USD in 2028. This suggests a diminishing market demand.
Variation:
- From 2023 to 2024: -4.2%
- From 2022 to 2023: -4.9%
- 5-year CAGR: -5.4%
Future trends to watch for include the impact of emerging antibiotic resistance, shifts toward preventative care, and advancements in alternative treatments, which could further influence market dynamics. Additionally, policy changes and health initiatives by the Japanese government could also play a significant role in shaping future demand for antiinfective medicines.
